Celgene and Quanticel Pharmaceuticals announced a definitive share purchase agreement under which Celgene will acquire Quanticel Read the full story

Teva Pharmaceutical announced a proposal to acquire all of the outstanding shares of Mylan in a transaction valued at $40 billion Read the full story

Roche has acquired CAPP Medical, a genomics research company Read the full story

OptumRx and Catamaran have agreed to combine Read the full story

Teva and Auspex Pharmaceuticals have entered into a definitive merger agreement Read the full story

Janssen Pharmaceuticals has acquired XO1 Limited Read the full story

Valeant increased the offer price to acquire all the outstanding common stock of Salix from $158.00 per share to $173.00 per share Read the full story

GSK has agreed to the sale of 28.2 million ordinary shares in Aspen Pharmacare Holdings Read the full story